Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis

Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysis - SGLT2 inhibitors in PD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049848

Enrollment

Registered

2023-01-26

Start date

2023-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease under peritoneal dialysis

Interventions

Administration of SGLT2 inhibitors

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients under peritoneal dialysis

Exclusion criteria

Exclusion criteria: Peritonitis or intraperitoneal cancers

Design outcomes

Primary

Measure	Time frame
peritoneal equilibration test on the day of administration	—

Secondary

Measure	Time frame
Blood sugar level on the day of administration	—

Countries

Japan

Contacts

Public ContactMasayuki Tanemoto

International University of Health and Welfare Nephrology

mtanemoto-tky@umin.ac.jp0557819171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026